Issue 1/1998
Content (11 Articles)
Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050)
Shouqi Luo, Claude Labrie, Alain Bélanger, Bernard Candas, Fernand Labrie
Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study
Giuseppe Frasci, Pasquale Comella, Giuseppe D'Aiuto, Alfredo Budillon, Deborah Barbarulo, Renato Thomas, Immacolata Capasso, Rossana Casaretti, Antonio Daponte, Francesco Caponigro, Adriano Gravina, Luigi Maiorino, Giacomo Caratení, Alfonso Gentile, Giuseppe Comella
Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up
K. Landys, S. Persson, J. Kovařík, R. Hultborn, E. Holmberg
Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients
Hyun Cheol Chung, Sun Young Rha, Joon Oh Park, Nae Choon Yoo, Joo Hang Kim, Jae Kyung Roh, Jin Sik Min, Kyong Sik Lee, Byung Soo Kim, Jin Ju Kim
Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status
Yasuo Nomura, Mitsunori Shirouzu, Takahiro Takayama
Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer
Kristina Dalberg, Anders Mattsson, Kerstin Sandelin, Lars E. Rutqvist
Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancer
Sadako Akashi-Tanaka, Takashi Fukutomi, Kunihisa Miyakawa, Nachiko Uchiyama, Hitoshi Tsuda
A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer
Gabi Schulgen, Claudia Schmoor, Willi Sauerbrei, Martin Schumacher